BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 37444627)

  • 1. Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms.
    Bocian-Jastrzębska A; Malczewska-Herman A; Rosiek V; Kos-Kudła B
    Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected Serum Biomarkers (Leptin, Chromogranin A, CA19-9, CEA) in Patients with Pancreatic Neuroendocrine Neoplasm and Associations with Metabolic Syndrome.
    Rosiek V; Bocian-Jastrzębska A; Kos-Kudła B
    Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impact of tumour burden in stage IV neuroendocrine neoplasia: A comparison between pancreatic and gastrointestinal localizations.
    Panzuto F; Pusceddu S; Faggiano A; Rinzivillo M; Brighi N; Prinzi N; Riccardi F; Iannicelli E; Maggio I; Femia D; Tafuto S; Manuzzi L; Di Sarno A; Annibale B; de Braud F; Campana D;
    Pancreatology; 2019 Dec; 19(8):1067-1073. PubMed ID: 31587962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis.
    Andreasi V; Ricci C; Partelli S; Guarneri G; Ingaldi C; Muffatti F; Crippa S; Casadei R; Falconi M
    J Endocrinol Invest; 2022 Apr; 45(4):705-718. PubMed ID: 34773595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance Between the Ki-67 Index Cutoff Value of 55% and Differentiation in Neuroendocrine Tumor and Neuroendocrine Carcinoma in Grade 3 Pancreatic Neuroendocrine Neoplasms.
    Shi H; Chen L; Zhang Q; Lin Y; Jiang C; Yao H; Hou X; Chen M; Lin R; Chen J
    Pancreas; 2020; 49(10):1378-1382. PubMed ID: 33122528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history and clinical outcomes of pancreatic neuroendocrine neoplasms based on the WHO 2017 classification; a single-center experience of 30 years.
    Fujimori N; Miki M; Lee L; Matsumoto K; Takamatsu Y; Takaoka T; Teramatsu K; Suehiro Y; Murakami M; Igarashi H; Oono T; Ohtsuka T; Nakamura M; Koga Y; Oda Y; Ito T; Ogawa Y
    Pancreatology; 2020 Jun; 20(4):709-715. PubMed ID: 32360001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin immunoreactive pancreatic neuroendocrine neoplasm associated with main pancreatic duct dilation: a recognizable entity with excellent long-term outcome.
    Dioguardi Burgio M; Cros J; Panvini N; Depoilly T; Couvelard A; Ruszniewski P; de Mestier L; Hentic O; Sauvanet A; Dokmak S; Faccinetto A; Ronot M; Vilgrain V
    Eur Radiol; 2021 Nov; 31(11):8671-8681. PubMed ID: 33977308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
    Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
    J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The number of positive nodes accurately predicts recurrence after pancreaticoduodenectomy for nonfunctioning neuroendocrine neoplasms.
    Partelli S; Javed AA; Andreasi V; He J; Muffatti F; Weiss MJ; Sessa F; La Rosa S; Doglioni C; Zamboni G; Wolfgang CL; Falconi M
    Eur J Surg Oncol; 2018 Jun; 44(6):778-783. PubMed ID: 29610023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonin-Producing Neuroendocrine Neoplasms of the Pancreas: Clinicopathological Study of 25 Cases and Review of the Literature.
    Uccella S; Blank A; Maragliano R; Sessa F; Perren A; La Rosa S
    Endocr Pathol; 2017 Dec; 28(4):351-361. PubMed ID: 29063495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study.
    Mir MM; Mir R; Alghamdi MAA; Wani JI; Sabah ZU; Jeelani M; Marakala V; Sohail SK; O'haj M; Alharthi MH; Alamri MMS
    J Pers Med; 2022 May; 12(5):. PubMed ID: 35629157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of Association between Serum Adiponectin/Leptin Levels and Medullary Thyroid Cancer.
    Abooshahab R; Yaghmaei P; Ghadaksaz HG; Hedayati M
    Asian Pac J Cancer Prev; 2016; 17(8):3861-4. PubMed ID: 27644630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database.
    Yang Z; Shi G
    Eur J Surg Oncol; 2022 Oct; 48(10):2181-2187. PubMed ID: 35623986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do Canine Pancreatic Neuroendocrine Neoplasms Resemble Human Pancreatic Neuroendocrine Tumours? A Comparative Morphological and Immunohistochemical Investigation.
    de Vries C; Konukiewitz B; Weichert W; Klöppel G; Aupperle-Lellbach H; Steiger K
    J Comp Pathol; 2020 Nov; 181():73-85. PubMed ID: 33288156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adipocytokines in Patients with Chronic Kidney Disease Stage 5.
    Yahya RS; Atwa MA; El-Sayed IH; El-Ghanaam DM; Hussein DT; El-Taweel FA
    Clin Lab; 2016; 62(1-2):21-30. PubMed ID: 27012030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between Adipokines and Biomarkers of Alzheimer's Disease: A Cross-Sectional Study.
    Letra L; Matafome P; Rodrigues T; Duro D; Lemos R; Baldeiras I; Patrício M; Castelo-Branco M; Caetano G; Seiça R; Santana I
    J Alzheimers Dis; 2019; 67(2):725-735. PubMed ID: 30689587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report.
    Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A
    Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus.
    Kamel SM; Abdel Azeem Abd Elazeem MEMI; Mohamed RA; Kamel MM; Abdel Aleem Abdelaleem EA
    Int J Immunopathol Pharmacol; 2023; 37():3946320231154988. PubMed ID: 36718110
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating adipokines are associated with pre-eclampsia in women with type 1 diabetes.
    Kelly CB; Hookham MB; Yu JY; Lockhart SM; Du M; Jenkins AJ; Nankervis A; Hanssen KF; Henriksen T; Garg SK; Hammad SM; Scardo JA; Aston CE; Patterson CC; Lyons TJ
    Diabetologia; 2017 Dec; 60(12):2514-2524. PubMed ID: 28875223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The assessment of serum concentration of adiponectin, leptin and serum carbohydrate antigen-19.9 in patients with pancreatic cancer and chronic pancreatitis.
    Dranka-Bojarowska D; Lekstan A; Olakowski M; Jablonska B; Lewinski A; Musialski P; Sobczyk W; Kapalka A; Lampe P
    J Physiol Pharmacol; 2015 Oct; 66(5):653-63. PubMed ID: 26579571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.